Impaired exercise performance in systemic sclerosis and its clinical correlations

References

• Seibold JR. Scleroderma. In: Harris ED, Budd RC, Firestein GS, editors. Kelley’s textbook of rheumatology, 7th edn. Philadelphia, PA: Elsevier Saunders, 2005:1279–308.
   Google Scholar
• Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987;91:118–27.
   PubMed Web of Science ®Google Scholar
• White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 2003:29;371–90.
   PubMed Web of Science ®Google Scholar
• Denton CP, Black CM. Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am 2003:29;335–49.
   PubMed Web of Science ®Google Scholar
• Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Pölzleitner D, Burghuber OC, Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755–9.
   PubMed Web of Science ®Google Scholar
• Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST variant of systemic sclerosis. Arthritis Rheum 1986;29:515–24.
   PubMed Web of Science ®Google Scholar
• Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006;54:184–91.
   PubMed Web of Science ®Google Scholar
• Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989–93.
   PubMedGoogle Scholar
• Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985;55:22A–31A.
   PubMed Web of Science ®Google Scholar
• Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am J Respir Crit Care Med 1996;154:994–1101.
   PubMedGoogle Scholar
• Dautzker DR, D’Alonzo GE. Pulmonary gas exchange and exercise performance in pulmonary hypertension. Chest 1985;88:255S–7S.
   PubMedGoogle Scholar
• Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994;150:1616–22.
   PubMed Web of Science ®Google Scholar
• Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, Effects of exercise training on LVF and peripheral resistance in patients with chronic heart failure: a randomized trial. J Am Med Assoc 2000;283:3095–101.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J. Combination therapy with bosentan and sildenafil in idiopathic pulmonary hypertension. Eur Respir J 2004;24:107–10.
   PubMedGoogle Scholar
• Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993;95:413–18.
   PubMed Web of Science ®Google Scholar
• Schwaiblamair M, Behr J, Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996;110:1520–5.
   PubMedGoogle Scholar
• Morelli S, Ferrante L, Sgreccia A, Eleuteri ML, Perrone C, De Marzio P, Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000;29:236–42.
   PubMed Web of Science ®Google Scholar
• de Oliveira NC, dos Santos Sabbag LM, Ueno LM, de Souza RB, Borges CL, de Sà Pinto AL, Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007;36:458–61.
   PubMed Web of Science ®Google Scholar
• Ries MD, Philbin EF, Groff GD. Relationship between severity of gonarthrosis and cardiovascular fitness. Clin Orthop Relat Res 1995;313:169–76.
   PubMedGoogle Scholar
• Philbin EF, Groff GD, Ries MD, Miller TE. Cardiovascular fitness and health in patients with end-stage osteoarthritis. Arthritis Rheum 1995;38:799–805.
   PubMed Web of Science ®Google Scholar
• Carter R, Riantawan P, Banham SW, Sturrock RD. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med 1999;93:700–8.
   PubMed Web of Science ®Google Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003;21(Suppl 29):S47–8.
   PubMedGoogle Scholar
• Valentini G, Medsger TA Jr, Silman AJ. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc. Clin Exp Rheumatol 2003;21(Suppl 29):S49–56.
   PubMedGoogle Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592–8.
   PubMed Web of Science ®Google Scholar
• Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21(Suppl 29):S42–6.
   PubMedGoogle Scholar
• Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27–31.
   PubMedGoogle Scholar
• American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107–36.
   PubMed Web of Science ®Google Scholar
• Coates AL, Peslin R, Rodenstein D, Stocks J. Measurement of lung volumes by plethysmography. Eur Respir J 1997; 10:1415–27.
   PubMed Web of Science ®Google Scholar
• Blakemore WS, Forster RE, Morton JW, Ogilvie CM. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957;36:1–17.
   PubMedGoogle Scholar
• Picillo U, Migliaresi S, Vatti M, Marcialis MR, Ferruzzi AM, Tirri G. Demographic differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216–18.
   PubMedGoogle Scholar
• Forte S, Carlone S, Vaccaro F, Onorati P, Manfredi F, Serra P, Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus. J Rheumatol 1999;26:2591–4.
   PubMed Web of Science ®Google Scholar
• Kampolis C, Plaatiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anticentromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol 2008;37:278–83.
   PubMed Web of Science ®Google Scholar
• Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Pre-clinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Am J Cardiol 2000;85:473–7.
   PubMed Web of Science ®Google Scholar
• Maione S, Cuomo G, Giunta A, Tanturri de Horatio L, La Montagna G, Manguso F, Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005;34:721–7.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984–91.
   PubMed Web of Science ®Google Scholar
• Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001;44:653–61.
   PubMedGoogle Scholar
• Sandqvist G, Hesselstrand R, Eberhardt K. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol 2009;38:304–10.
   PubMed Web of Science ®Google Scholar
• Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:441–7.
   PubMed Web of Science ®Google Scholar
• Schoindre Y, Meune C, Dinh-Xuan AT, Avouac J, Kahan A, Allanore Y. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis. J Rheumatol 2009;36:1481–5.
   PubMedGoogle Scholar